Long-term sleep apnea as a pathogenic factor for cell-mediated autoimmune disease

Medical Hypotheses

Volumn 65, Issue 6, 2005, Pages 1024-1027

  Abrams, Burton ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; URATE;

ARTICLE; AUTOIMMUNE DISEASE; CELL DAMAGE; CELLULAR IMMUNITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; GOUT; HUMAN; HYPOTHESIS; IMMUNOSTIMULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REMISSION; SLEEP APNEA SYNDROME; T LYMPHOCYTE ACTIVATION; UREMIA;

AUTOIMMUNE DISEASES; CAUSALITY; HUMANS; IMMUNITY, CELLULAR; MODELS, IMMUNOLOGICAL; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SLEEP APNEA SYNDROMES; T-LYMPHOCYTES;

EID: 26444608431     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.05.046     Document Type: Article

References (37)

1. C.M. Grum Cells in crisis: cellular bioenergenics and inadequate oxygenation in the intensive care unit Chest 102 2 1992 329 330
2. J.D. Hasday, and C.M. Grum Nocturnal increase of urinary uric acid:creatine ratio: a biological correlate of sleep-associated hypoxemia Am Rev Respir Dis 135 1987 534 538
3. B. Abrams Gout is an indicator of sleep apnea J Sleep 28 2 2005 275
4. Y. Shi, J.E. Evans, and K.L. Rock Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 2003 516 521
5. B. Pulendran Immune activation: death, danger and dendritic cells Curr Biol 14 1 2004 R30 R32
6. H. Drakesmith, B. Chain, and P. Beverley How can dendritic cells cause autoimmune disease? Immun Today 21 5 2000 214 217
7. P.A. Morel, M. Feili-Harriri, P.T. Coates, and A.W. Thomson Dendritic cells, T cell tolerance and therapy of adverse immune reactions Clin Exp Immunol 133 1 2003 1 10
8. A. Mehling, and S. Beissert Dendritic cells under investigation in autoimmune disease Crit Rev Biochem Mol Biol 38 1 2003 1 21
9. B. Ludewig, T. Junt, H. Hengartner, and R.M. Zinkernagel Dendritic cells in autoimmune diseases Curr Opin Immunol 13 6 2001 657 662
10. L.K. Brown A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome Chest 2002 774 778
11. M. Pietropaolo, E. Barinas-Mitchell, L.H. Kuller, and M. Trucco Is type 2 diabetes a chronic inflammatory-autoimmune disease? Diabetes 49 1 2000 32 38
12. B.M. Brooks-Worrell, R. Juneja, A. Minokadeh, C.J. Greenbaum, and J.P. Palmer Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients Diabetes 48 5 1999 983 988
13. J.P. Palmer Beta cell rest and recovery - does it bring patients with latent autoimmune diabetes in adults to euglycemia Ann N Y Acad Sci 958 2002 89 98
14. E. Kawasaki Epitope analysis of GAD65 autoantibodies in Japanese patients with autoimmune diabetes Ann N Y Acad Sci 1005 2003 440 448
15. J.C. Pickup Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes Diabetes Care 27 3 2004 813 823
16. R. Wolk, and V.K. Somers Cardiovascular consequences of obstructive sleep apnea Clin Chest Med 24 2 2003 195 205
17. J.L. Arter, D.S. Chi, M. Girish, S.M. Fitzgerald, B. Guha, and G. Krishnaswamy Obstructive sleep apnea, inflammation, and cardiopulmonary disease Front Biosci 9 2004 2892 2900
18. A.S. Shamsuzzaman, M. Winnicki, P. Lanfranchi, R. Wolk, T. Kara, and V. Accurso Elevated C-reactive protein in patients with obstructive sleep apnea Circulation 105 21 2002 2462 2464
19. S. Teramoto, H. Yamamoto, Y. Yamaguchi, R. Namba, and Y. Ouchi Obstructive sleep apnea causes systemic inflammation and metabolic syndrome Chest 127 3 2005 1074 1075
20. T. Young, P.E. Peppard, and D.J. Gottlieb Epidemiology of obstructive sleep apnea: a population health perspective Am J Respir Crit Care Med 165 4 2001 1217 1239
21. J.J. Guardiola, P.J. Matheson, L.C. Clavijo, M.A. Wilson, and E.C. Fletcher Hypercoagulability in patients with obstructive sleep apnea Sleep Med 2 6 2001 517 523
22. R. von Kanel, and J.E. Dimsdale Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease Chest 124 5 2003 1956 1967
23. M.J. Kahn Hypercoagulability as a cause of stroke in adults South Med J 6 4 2003 350 353
24. H.A. Anderson, and E. Shacter Natural anticoagulant proteins in the regulation of autoimmunity: potential role of protein S Curr Pharm Des 10 8 2004 929 937
25. M.A. Quera-Salva Breathing disorders during sleep in myasthenia gravis Ann Neurol 31 1 1992 86 92
26. S. Erden, T. Cagatay, S. Buyukozturk, E. Kiyan, and C. Cuhadaroglu Hashimoto thyroiditis and obstructive sleep apnea syndrome: is there any relation between them? Eur J Med Res 9 12 2004 570 572
27. M.G. Poluektov Sleep apnea in neurological disorders Zh Nevrol Psikhiatr Im S S Korsakova 104 3 2004 4 7
28. L. Wawrzynska Autoimmune thyroid diseases in patients with primary pulmonary hypertension Pneumonol Alergol Pol 72 1-2 2004 19 22
29. J.W. Chu, P.N. Kao, J.L. Faul, and R.L. Doyle High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension Chest 122 5 2002 1668 1673
30. C.L. Vanderlugt, and S.D. Miller Epitope spreading in immune-mediated diseases: implications for immunotherapy Nat Rev Immunol 2 2 2002 85 95
31. A.R. Babu, J. Herdegen, L. Fogelfeld, S. Shott, and T. Mazzone Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea Arch Intern Med 165 4 2005 447 452
32. O. Milleron Benefits of obstructive sleep apnea treatment in coronary artery disease: a long-term follow-up study Eur Heart J 25 9 2004 709 711
33. I.A. Harsch, E.G. Hahn, and P.C. Konturek Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome Med Sci Monit 11 3 2005 RA70 RA75
34. A. Qureshi, and R.D. Ballard Obstructive sleep apnea J Allergy Clin Immunol 112 4 2003 643 651
35. M.R. Namazi Celtrizine and allopurinol as novel weapons against cellular autoimmune disease Int Immunopharmacol 4 3 2004 349 353
36. F.H. Grus, A.J. Augustin, K. Loeffler, J. Lutz, and N. Pfeiffer Immunological effects of allopurinol in the treatment of experimental autoimmune uveitis (EAU) after onset of the disease Eur J Ophthalmol 13 2 2003 185 191
37. Z. Tsutsumi, Y. Moriwaki, S. Takahashi, T. Ka, and T. Yamamoto Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate lowering therapy Clin Chim Acta 339 1-2 2004 117 122